Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00418
Species: Homo sapiens
Position : chr3:128603426-128604425
Year: 2021
Title: The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Normal
PMID:  34584081
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Primary human CD34+ hematopoietic stem/progenitor cells
Cell Type: CD34-positive hematopoietic stem/progenitor cell
Experiment Type: Native enhancer TF-binding/chromatin-state validation
High Throughput Method: H3K27ac ChIP-seq; hematopoietic TF ChIP-seq; structural-variant mapping; RNA-seq
Low Throughput Method: Targeted ChIP validation; RT-qPCR; CRISPR-Cas9
About Target Gene
Target gene : GATA2
About TF
TF name : RUNX1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
RUNX1 AndrogenReceptor netpath 167
RUNX1 Organic cation transport reactome 9
RUNX1 RANKL netpath 84
RUNX1 Regulation of nuclear SMAD2/3 signaling pid 82
RUNX1 TGF_beta_Receptor netpath 220
RUNX1 Validated transcriptional targets of deltaNp63 isoforms pid 47
RUNX1 Pathways in cancer kegg 321
RUNX1 Chronic myeloid leukemia kegg 69
RUNX1 Acute myeloid leukemia kegg 53
Enhancer Associated Network
Overlapping Enhancers (hg38) 5 found
Enhancer ID Position Tissue Cell Disease
E_00340 chr3:128603426-128604425 bone marrow myeloid leukemia blast cell acute myeloid leukemia
E_00392 chr3:128603426-128604425 bone marrow myeloid leukemia blast cell acute myeloid leukemia
E_03951 chr3:128603821-128604120 bone marrow myeloid leukemia cell acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
E_03979 chr3:128603821-128604120 bone marrow myeloid leukemia cell acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
E_04324 chr3:128603821-128604120 bone marrow hematopoietic stem/progenitor cell acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
Expression of Target Genes for the Enhancer